|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Clovis Oncology, Inc. (CLVS) |
|
|
$0.02 0.00 (0.00%) as of 4:30 Mon 7/10
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
88,200,000 |
Market
Cap: |
1.32(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.0103 - $0.0388 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents. Co. markets Rubraca®, which is an oral small molecule inhibitor of poly ADP-ribose polymerase for indications specific to recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer. Co.'s product candidates include: FAP-2286, a peptide-targeted radionuclide therapy and imaging agent targeting fibroblast activation protein; and Lucitanib, an oral potent angiogenesis inhibitor which inhibits vascular endothelial growth factor receptors 1 through 3, platelet-derived growth factor receptors alpha and beta and fibroblast growth factor receptors 1 through 3.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
60,798 |
Total Sell Value |
$0 |
$0 |
$0 |
$67,533 |
Total People Sold |
0 |
0 |
0 |
5 |
Total Sell Transactions |
0 |
0 |
0 |
26 |
End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Blair James C |
Director |
|
2017-08-16 |
4 |
A |
$0.00 |
$0 |
D/D |
4,835 |
7,020 |
|
- |
|
Blair James C |
Director |
|
2017-08-16 |
4 |
D |
$0.00 |
$0 |
I/I |
(92,518) |
0 |
|
- |
|
Ivers-Read Gillian C |
See Remarks |
|
2017-08-15 |
4 |
AS |
$70.05 |
$210,150 |
D/D |
(3,000) |
194,583 |
|
- |
|
Blair James C |
Director |
|
2017-08-04 |
4 |
S |
$78.61 |
$1,450,355 |
I/I |
(18,450) |
17,056 |
|
- |
|
Ivers-Read Gillian C |
See Remarks |
|
2017-07-17 |
4 |
AS |
$91.56 |
$274,680 |
D/D |
(3,000) |
197,583 |
|
- |
|
Atwood Brian G |
Director |
|
2017-06-26 |
4 |
A |
$0.00 |
$0 |
I/I |
5,210 |
25,577 |
|
- |
|
Blair James C |
Director |
|
2017-06-23 |
4 |
A |
$0.00 |
$0 |
I/I |
2,869 |
92,518 |
|
- |
|
Blair James C |
Director |
|
2017-06-23 |
4 |
D |
$0.00 |
$0 |
I/I |
(286,857) |
1,000,000 |
|
- |
|
Ivers-Read Gillian C |
See Remarks |
|
2017-06-15 |
4 |
AS |
$61.82 |
$185,460 |
D/D |
(3,000) |
200,583 |
|
- |
|
Ivers-Read Gillian C |
See Remarks |
|
2017-05-15 |
4 |
AS |
$47.39 |
$142,170 |
D/D |
(3,000) |
203,583 |
|
- |
|
Ivers-Read Gillian C |
See Remarks |
|
2017-04-17 |
4 |
AS |
$56.02 |
$168,060 |
D/D |
(3,000) |
206,583 |
|
- |
|
Muehl Daniel W |
See Remarks |
|
2017-03-08 |
4 |
D |
$59.27 |
$23,708 |
D/D |
(400) |
850 |
|
- |
|
Muehl Daniel W |
See Remarks |
|
2017-03-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,250 |
1,250 |
|
- |
|
Barrett M James |
Director |
|
2017-02-27 |
4 |
A |
$0.00 |
$0 |
I/I |
11,686 |
861 |
|
- |
|
Barrett M James |
Director |
|
2017-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
287 |
861 |
|
- |
|
Barrett M James |
Director |
|
2017-02-27 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,151,289) |
0 |
|
- |
|
Hooks Corwin Dale |
See remarksOfficer |
|
2016-02-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
703 |
|
- |
|
Mast Erle T |
Executive VP and CFO |
|
2015-11-02 |
4 |
AS |
$98.82 |
$316,679 |
D/D |
(3,000) |
135,583 |
|
- |
|
Rolfe Lindsey |
See Remarks |
|
2015-10-28 |
4 |
AS |
$95.78 |
$392,064 |
D/D |
(4,000) |
0 |
|
- |
|
Rolfe Lindsey |
See Remarks |
|
2015-10-28 |
4 |
OE |
$3.08 |
$12,320 |
D/D |
4,000 |
4,000 |
|
- |
|
Ivers-Read Gillian C |
See Remarks |
|
2015-10-15 |
4 |
AS |
$91.91 |
$275,730 |
D/D |
(3,000) |
212,583 |
|
- |
|
Rolfe Lindsey |
See Remarks |
|
2015-10-05 |
4 |
AS |
$91.84 |
$372,159 |
D/D |
(4,000) |
0 |
|
- |
|
Rolfe Lindsey |
See Remarks |
|
2015-10-05 |
4 |
OE |
$3.08 |
$12,320 |
D/D |
4,000 |
4,000 |
|
- |
|
Mast Erle T |
Executive VP and CFO |
|
2015-10-01 |
4 |
AS |
$89.40 |
$270,657 |
D/D |
(3,000) |
138,583 |
|
- |
|
Blair James C |
Director |
|
2015-09-22 |
4 |
D |
$0.00 |
$0 |
I/I |
(794,888) |
1,286,857 |
|
- |
|
509 Records found
|
|
Page 19 of 21 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|